Tony Chou, MD

Title(s)Associate Clinical Professor, Medicine
SchoolSchool of Medicine
Address505 Parnassus Avenue
San Francisco CA 94117
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoClinical Fellowship School of Medicine - Internal Medicine
    University of California, San FranciscoResidency School of Medicine

    Collapse Overview 
    Collapse Overview
    Tony M. Chou is a general partner at the Vertical Group, a venture capital firm focused on the fields of medical technology and biotechnology.

    As an investor, Dr. Chou serves on the Board of Directors of several venture-backed companies.

    Additional UCSF service includes participation as a member of the Masters of Translational Medicine Advisory Board. The MTM is a joint masters-level program which spans UCSF and UC Berkeley.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study. J Vasc Surg. 2011 Nov; 54(5):1317-23. Pinter L, Ribo M, Loh C, Lane B, Roberts T, Chou TM, Kolvenbach RR. PMID: 21658889.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    2. A "grapple hook" technique using a deflectable tip catheter to facilitate complex proximal circumflex interventions. Catheter Cardiovasc Interv. 2006 Jan; 67(1):46-8. McNulty E, Cohen J, Chou T, Shunk K. PMID: 16331693.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol. 2005 Oct; 17(10):504-10. Hermiller J, Simonton C, Hinohara T, Lee D, Cannon L, Mooney M, O'Shaughnessy C, Carlson H, Fortuna R, Yarbrough CA, Zapien M, Chou T. PMID: 16204741.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    4. Initial experience with a new femoral artery closure device following percutaneous coronary intervention with glycoprotein IIb/IIIa inhibition. Catheter Cardiovasc Interv. 2005 Oct; 66(2):185-91. Ruygrok PN, Ormiston JA, Stewart JT, Webster MW, El Jack S, Simpson-Plaumann S, Kay IP, Chou TM. PMID: 16152652.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Dehydroepiandrosterone sulfate induces acute vasodilation of porcine coronary arteries in vitro and in vivo. J Cardiovasc Pharmacol. 2005 Sep; 46(3):325-32. Hutchison SJ, Browne AE, Ko E, Chou TM, Zellner C, Komesaroff PA, Chatterjee K, Sudhir K. PMID: 16116338.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    6. Vascular complications and arteriotomy closure devices during percutaneous coronary procedures. J Am Coll Cardiol. 2005 Jun 21; 45(12):2095-6; author reply 2096. Chou TM. PMID: 15963417.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. StarClose femoral arteriotomy closure device: an advance in arterial closure. Expert Rev Med Devices. 2005 May; 2(3):247-52. Ruygrok PN, Chou TM. PMID: 16288587.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Effect of intracoronary estradiol on postischemic microvascular damage in a porcine model: a myocardial contrast echocardiographic study. Angiology. 2003 Nov-Dec; 54(6):701-9. Nishino M, Youn HJ, Gheorghevici D, Zellner C, Chou TM, Sudhir K, Redberg RF. PMID: 14666959.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    9. Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results. Circulation. 2003 Sep 16; 108(11):1310-5. Kereiakes DJ, Szyniszewski AM, Wahr D, Herrmann HC, Simon DI, Rogers C, Kramer P, Shear W, Yeung AC, Shunk KA, Chou TM, Popma J, Fitzgerald P, Carroll TE, Forer D, Adelman DC. PMID: 12939212.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    10. Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium. Catheter Cardiovasc Interv. 2002 Nov; 57(3):387-94. Chou TM, Woodburn KW, Cheong WF, Lacy SA, Sudhir K, Adelman DC, Wahr D. PMID: 12410519.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    11. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J Invasive Cardiol. 2002 Jun; 14(6):299-302. Michaels AD, Appleby M, Otten MH, Dauterman K, Ports TA, Chou TM, Gibson CM. PMID: 12042618.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    12. Effects of enhanced external counterpulsation on Health-Related Quality of Life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation. J Investig Med. 2002 Jan; 50(1):25-32. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, Nesto R, Ferrans CE, Keller S. PMID: 11813825.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    13. The Role of Platelet-Targeted Strategies in Managing the Spectrum of Unstable Angina and Non-Q Wave Myocardial Infarction: Clinical Trials with Glycoprotein IIb/IIIa Inhibitors. J Invasive Cardiol. 1998 Dec; 10 Suppl D:8D-11D. Chou TM, Grossman W. PMID: 10762993.
      View in: PubMed   Mentions:    Fields:    
    14. Catheter-based intervention: pushing the envelope. J Am Coll Cardiol. 1998 Mar 01; 31(3):567-9. Chou TM. PMID: 9502636.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Tropomyosin lysine reactivities and relationship to coiled-coil structure. Biochemistry. 1985 Jun 18; 24(13):3305-14. Hitchcock-DeGregori SE, Lewis SF, Chou TM. PMID: 3927977.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    Tony's Networks
    Concepts (122)
    Derived automatically from this person's publications.
    Co-Authors (4)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department